Effects of methylprednisolone on human myeloid leukemic cells in vitro.
We have demonstrated previously that high-dose methylprednisolone treatment induces differentiation and apoptosis of leukemic cells in patients with different morphological subtypes of acute myeloblastic leukemia (AML) in vivo. In the present study, we investigated the in vitro effects of high (10(-3) M) and low (10(-6) M) concentrations of methylprednisolone (MP) on freshly isolated bone marrow leukemic cells from nine newly diagnosed patients with AML by light and electron microscopy (EM) and agarose gel electrophoresis. A marked increase in MP-induced apoptosis of leukemic cells, with a maximum effect at 24 hr of exposure to both low and high concentrations of MP (10(-6) M and 10(-3) M), was demonstrated by light microscopy in cultures of four (three with AML-M1 and one with AML-M7) of the nine patients. In three cases, the increase in the number of apoptotic cells induced by high-concentration MP was approximately twice that observed when the lower concentration was used. A few apoptotic cells were detected in the cultures from the other five patients. However, a typical DNA ladder pattern of apoptosis was observed on gel electrophoresis of MP-treated leukemic cells from one patient (AML-M1) after 2 hr of incubation with both high- and low-MP concentrations. In two patients, a nonspecific DNA smear was observed only when high-concentration MP was used. The increase in differentiated leukemic cells induced by MP was also dose dependent, and was observed in cultures from all but one patient. Morphological features of apoptosis and differentiation were also confirmed by EM studies. The results of the present study, together with our previous clinical experience, suggest that MP, especially at high doses, could have a significant role in the treatment of some AML patients by inducing apoptosis and differentiation of leukemic cells.
Ozbek
N
N
Department of Pediatric Hematology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Erdemli
E
E
Hiçsönmez
G
G
Okur
H
H
Tekelioğlu
M
M
D000293:Adolescent; D017209:Apoptosis / Q000187:drug effects*; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D002454:Cell Differentiation; D002648:Child; D053938:DNA Fragmentation; D004587:Electrophoresis, Agar Gel; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008854:Microscopy, Electron; D014407:Tumor Cells, Cultured
D005938:Glucocorticoids; D008775:Methylprednisolone